Isolated REM-sleep behavior disorder is a condition that can provide an indication of Parkinson's disease well in advance. A research team headed by Professor Dr. Erdem Gültekin Tamgüney from Heinrich Heine University Düsseldorf ...
Feb 16, 2023
0
40
Neurodegenerative disorders like Alzheimer's and Parkinson's disease result from the loss of specific types of neurons due to abnormal accumulation of mutant proteins. Although specific brain regions have been found to be ...
Dec 27, 2022
0
170
Deep brain stimulation (DBS) is an established treatment option for patients suffering from Parkinson's disease. In a neurosurgical procedure two electrodes are implanted in the brain to permanently stimulate specific brain ...
Dec 21, 2022
0
55
New research from the University of Alabama at Birmingham says the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson's disease. The findings, published in Nature Communications, show a wide ...
Dec 1, 2022
0
1243
ETH Zurich researchers have found that a set of proteins have different shapes in the spinal fluid of healthy individuals and Parkinson's patients. These could be used in the future as a new type of biomarker for this disease.
Nov 25, 2022
0
935
By measuring immune cells in the cerebrospinal fluid when diagnosing ALS, it is possible to predict how fast the disease may progress according to a study from Karolinska Institutet published in Nature Communications.
Nov 23, 2022
0
34
Scientists affiliated with the Department of Physical Education's Human Movement Laboratory (Movi-Lab) at São Paulo State University (UNESP) in Bauru, Brazil, are using artificial intelligence to help diagnose Parkinson's ...
Nov 23, 2022
0
42
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has identified a new hallmark of the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS), revealing a likely ...
Nov 22, 2022
0
49
After Alzheimer's, Parkinson's is the most common neurodegenerative disease in the world. More than six million people worldwide suffer from it. In this disease, alpha-synuclein proteins form thread-like structures called ...
Nov 15, 2022
0
980
Testing whether a new drug impacts the progression of Parkinson's disease takes years, in part because the disease often advances so slowly. Many Parkinson's patients don't have any worsening of their symptoms over the course ...
Nov 10, 2022
0
18
